申请人:Lee Hyun-Joo
公开号:US20130338179A1
公开(公告)日:2013-12-19
The present invention provides a diaminopyrimidine derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, a pharmaceutical composition comprising the same, and a use thereof. The diaminopyrimidine derivative or its pharmaceutically acceptable salt functions as a 5-HT
4
receptor agonist, and therefore can be usefully applied for preventing or treating dysfunction in gastrointestinal motility, one of the gastrointestinal diseases, such as gastroesophageal reflux disease (GERD), constipation, irritable bowel syndrome (IBS), dyspepsia, post-operative ileus, delayed gastric emptying, gastroparesis, intestinal pseudo-obstruction, drug-induced delayed transit, or diabetic gastric atony.
本发明提供了一种二氨基嘧啶衍生物或其药学上可接受的盐,以及其制备方法、包含相同的药物组合物和使用方法。该二氨基嘧啶衍生物或其药学上可接受的盐作为5-HT4受体激动剂,因此可用于预防或治疗胃肠动力功能障碍等胃肠疾病,如胃食管反流病(GERD)、便秘、肠易激综合征(IBS)、消化不良、术后肠麻痹、胃排空延迟、胃麻痹、肠假性梗阻、药物诱导的肠道传输延迟或糖尿病性胃失神。